PheWAS of extreme rare variants (MAF < 0.1%), using burden test methodology, provided an initial exploratory association of the MC4R coding variants with abnormal glucose test, presence of casts in urine, dysmetabolic syndrome X, pituitary hypofunction, and neurofibromatosis. This evidence concerns the gene MC4R and neurofibromatosis.